World's Best Scientists 2026 revealed!
Hidetoshi Eguchi

Hidetoshi Eguchi

D-Index & Metrics

Medicine

D-Index
82
Citations
26100
World Ranking
16060
National Ranking
500

Hidetoshi Eguchi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Hidetoshi Eguchi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,141 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Hidetoshi Eguchi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Hidetoshi Eguchi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Hidetoshi Eguchi is affiliated with Osaka University in Japan and has a significant body of work focused on medical research, primarily within the field of medicine. Their research spans several subfields including surgery, oncology, pulmonary and respiratory medicine, molecular biology, and cancer research.

The scientist's research covers a variety of topics, notably pancreatic and hepatic oncology, gastric cancer management and outcomes, esophageal cancer research and treatment, colorectal cancer surgical treatments, cholangiocarcinoma and gallbladder cancer studies, esophageal and gastrointestinal pathology, and gastrointestinal tumor research and treatment.

Recent publications by Hidetoshi Eguchi illustrate their focus on cancer-related clinical and molecular studies. Selected recent papers include:

  • Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA), 2022, Journal of Hepato-Biliary-Pancreatic Sciences
  • Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production, 2020, Gastroenterology
  • Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma, 2022, Hepatology
  • Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis, 2023, International Journal of Clinical Oncology
  • Spatial and single-cell transcriptomics decipher the cellular environment containing HLA-G+ cancer cells and SPP1+ macrophages in colorectal cancer, 2023, Cell Reports

Frequent co-authors in Hidetoshi Eguchi's work include Yuichiro Doki, Shogo Kobayashi, Yukinori Kurokawa, Tomoki Makino, and Kotaro Yamashita. These collaborators have contributed to numerous publications, indicating ongoing collaborative research efforts.

Publication venues where Hidetoshi Eguchi has published frequently include:

  • Annals of Surgical Oncology
  • Annals of Gastroenterological Surgery
  • Scientific Reports
  • Anticancer Research
  • Research Square

The concentration of published work in oncology, surgery, and gastrointestinal cancers aligns with the primary topics of pancreatic and hepatic oncology research as well as other gastrointestinal malignancies.

Best Publications

  • Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer

    T Matsumura;K Sugimachi;H Iinuma;Y Takahashi

  • Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

    Yoshito Tomimaru;Hidetoshi Eguchi;Hiroaki Nagano;Hiroshi Wada

  • A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation

    Kunihito Gotoh;Terumasa Yamada;Osamu Ishikawa;Hidenori Takahashi

  • Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers

    Y Takahashi;G Sawada;J Kurashige;R Uchi

  • Fucosylated haptoglobin is a novel marker for pancreatic cancer : A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

    Noriko Okuyama;Yoshihito Ide;Miyako Nakano;Tsutomu Nakagawa

  • Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population

    Genta Sawada;Genta Sawada;Atsushi Niida;Ryutaro Uchi;Hidenari Hirata

  • Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation

    K Sugimachi;T Matsumura;H Hirata;R Uchi

  • Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.

    Satoshi Tanaka;Hayato Hikita;Tomohide Tatsumi;Ryotaro Sakamori

  • MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.

    Manabu Mikamori;Daisaku Yamada;Hidetoshi Eguchi;Shinichiro Hasegawa

  • Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.

    Motoi Kondo;Hirofumi Yamamoto;Hiroaki Nagano;Jiro Okami

  • MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.

    Y Tomimaru;H Eguchi;H Nagano;H Wada

  • Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

    Sohei Satoi;Hiroki Yamaue;Kentaro Kato;Shinichiro Takahashi

  • Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon

    Ho Min Kim;Naotsugu Haraguchi;Hideshi Ishii;Hideshi Ishii;Masahisa Ohkuma

  • Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-|[alpha]| and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

    H Ota;H Nagano;M Sakon;H Eguchi

  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer

    Tomohiro Iguchi;Ryutaro Uchi;Sho Nambara;Tomoko Saito

  • Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular Carcinoma

    Yo Sasaki;Terumasa Yamada;Hideo Tanaka;Hiroaki Ohigashi

  • Adipose-derived mesenchymal stem cells and regenerative medicine.

    Masamitsu Konno;Atsushi Hamabe;Shinichiro Hasegawa;Hisataka Ogawa

  • Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases.

    Keisuke Taniuchi;Hidewaki Nakagawa;Masayo Hosokawa;Toru Nakamura

  • γ-Aminobutyric Acid (GABA) Stimulates Pancreatic Cancer Growth through Overexpressing GABAA Receptor π Subunit

    Akio Takehara;Masayo Hosokawa;Hidetoshi Eguchi;Hiroaki Ohigashi

  • CKAP4 is a Dickkopf1 receptor and is involved in tumor progression

    Hirokazu Kimura;Katsumi Fumoto;Kensaku Shojima;Satoshi Nojima

Frequent Co-Authors

Yuichiro Doki
Yuichiro Doki Osaka University
Masaki Mori
Masaki Mori Kyushu University
Hiroaki Nagano
Hiroaki Nagano Osaka University
Koshi Mimori
Koshi Mimori Kyushu University
Osamu Ishikawa
Osamu Ishikawa Gunma University
Hirofumi Yamamoto
Hirofumi Yamamoto Osaka University
Morito Monden
Morito Monden Osaka University
Eiji Miyoshi
Eiji Miyoshi Osaka University
Eiichi Morii
Eiichi Morii Osaka University
Hiroki Yamaue
Hiroki Yamaue Wakayama Medical University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA can open the door to a wide range of career paths online. Many professionals start by pursuing specialized certifications or associate degrees before advancing to higher-level qualifications. For those interested in healthcare administration, programs such as an accelerated healthcare administration degree online allow students to fast-track their careers while balancing other commitments.

Entry-level options include medical billing and coding, where attending medical billing and coding schools online with financial aid can make this essential healthcare role more accessible and affordable. Clinical careers, such as nursing, often require entrance exams, but some lpn program no entrance exam options are available, making it easier to begin a practical nursing journey.

Advancement opportunities also exist for nurses holding an ADN, thanks to adn to np bridge programs. These programs enable practicing RNs to move into advanced practice roles and expand their scope of impact in healthcare. Online study options offer flexibility, financial support, and opportunities for advancement at every stage of a healthcare career.

Best Scientists Citing Hidetoshi Eguchi

Trending Scientists

Recently Published Articles